AstraZeneca Plc is a global research and development biopharmaceutical company, principally engaged in the research, development and sale of prescription medicines covering gastrointestinal, cardiovascular, neurological, respiratory and infectious diseases. The company sells products under the brands Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Cytanest, Diprivan and Marcaine/Sensorcaine. AstraZeneca was founded on 6 April 1999 and is headquartered in London, UK.
Financial performance
- Capitalisation: 137.7 billion
- Annual turnover: 23.9 billion
- Revenue: 2.2 billion
- Assets: 60.7 billion
Company profile
- Year founded: 1999
- Head: Pascal Soriot
- Number of employees: 70600
- Head office: London, UK
Profile figures as last updated in August 2022. The company's own reports have the current ones.